Patterns of Failure Associated with Involved Field Radiotherapy in Patients with Clinical Stage I Thoracic Esophageal Cancer
Open Access
- 10 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 41 (8) , 1007-1012
Abstract
To analyze the patterns of the first sites of failure in patients with clinical stage I thoracic esophageal cancer after involved field radiotherapy and to determine whether elective nodal irradiation is necessary for these patients. Between 2000 and 2007, 68 patients aged 43–84 years with clinical stage I thoracic esophageal cancer received definitive radiotherapy. The radiation field included the primary tumor with a 3-cm margin in the cranio-caudal direction. Patterns of lymph node failure were classified according to the first sites of failure. In-field, regional and distant lymph node failures were defined as lymph node failures within the irradiated area, within the mediastinum or perigastric area beyond the irradiated area, and outside the regional lymph nodes, respectively. The 3 year overall and disease-free survival rates were 76 and 66%, respectively (median follow-up: 42 months). Twenty-two of the 68 patients exhibited treatment failure. Local failure with or without recurrence in other sites was observed in 11 patients, lymph node failure in 10 patients, and distant metastasis in 1. Of the 10 patients with lymph node failure, sites of failure were in-field in 1 patient, in-field and distant in 1, regional in 3, distant in 2 and distant and regional in 3. Involved field radiotherapy did not result in significant incidence of regional lymph node failure in clinical stage I thoracic esophageal cancer patients. However, further investigation is needed to establish the optimal radiotherapy field for clinical stage I thoracic esophageal cancer.Keywords
This publication has 18 references indexed in Scilit:
- Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasmsGastrointestinal Endoscopy, 2009
- Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagusRadiotherapy and Oncology, 2009
- A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708)Japanese Journal of Clinical Oncology, 2009
- Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: Indications for surgery or combined chemoradiotherapyJournal of Gastroenterology and Hepatology, 2006
- Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Long-Term Toxicity After Definitive Chemoradiotherapy for Squamous Cell Carcinoma of the Thoracic EsophagusJournal of Clinical Oncology, 2003
- INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation TherapyJournal of Clinical Oncology, 2002
- Treatment of superficial cancer of the esophagus: A summary of responses to a questionnaire on superficial cancer of the esophagus in JapanSurgery, 1998
- Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Endoscopic laser treatment of superficial esophageal cancerSeminars in Surgical Oncology, 1986